Circadian rhythmicity in emerging mood disorders: state or trait marker? by unknown
Grierson et al. Int J Bipolar Disord  (2016) 4:3 
DOI 10.1186/s40345-015-0043-z
RESEARCH
Circadian rhythmicity in emerging mood 
disorders: state or trait marker?
Ashlee B. Grierson1, Ian B. Hickie1, Sharon L. Naismith2, Daniel F. Hermens1, Elizabeth M. Scott3,4 and Jan Scott5*
Abstract 
Background: Circadian rhythm disturbances overlap with the symptoms of mood episodes and may trigger or 
prolong mood symptoms. There is limited research on the role of circadian disturbances in mood disorders in young 
people and/or first episode cases of unipolar and bipolar disorders.
Methods: Actigraphy was undertaken for about 14 days in 63 post-pubertal individuals aged 13–25 years with a 
recent onset of a mood disorder meeting recognised diagnostic criteria. We examined associations between three 
easily interpretable markers of circadian rhythm activity (amplitude, acrophase and rhythmicity index) and demogra-
phy and clinical characteristics. Then, circadian markers were compared between diagnostic groups, controlling for 
potential confounders.
Results: Longer duration of illness was correlated with reduced circadian rhythmicity and lower levels of activity over 
24 h. A delay in the timing of maximum activity was associated with the level of manic but not depressive symptoms. 
The circadian rhythmicity index differentiated unipolar from bipolar cases, and in bipolar but not unipolar disorder, 
the rhythmicity was less robust in those with more severe manic or depressive symptoms.
Conclusions: Less robust circadian rhythmicity, especially associated with increasing symptom severity, may repre-
sent a more specific or a trait marker of young people with mood disorders who are at higher risk of a bipolar course 
of illness.
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Background
Circadian rhythm disturbances are of considerable inter-
est to mood disorder researchers as many of the phenom-
ena that accompany disruptions in the sleep–wake cycle 
overlap with the symptoms of mood episodes or may 
trigger or prolong mood symptoms (e.g. McClung 2013; 
Robillard et  al. 2013a). However, most investigations 
of circadian rhythm disruptions in mood disorders are 
focused on older adult samples with established unipolar 
(UP) or bipolar disorders (BD). Often these individuals 
have a history of multiple mood episodes, accompanied 
by a high prevalence of mental and physical comorbidi-
ties, complex treatment regimens and/or elevated body 
mass index (BMI) (Geoffroy et  al. 2015). As such, it is 
difficult to disentangle which abnormalities represent 
causes and which are consequences of mood episodes 
(Bellivier et  al. 2015). There is limited research on the 
role of circadian disturbances in UP and BD in young 
people, especially related to first episode onset or the first 
treated episode (e.g. Ritter et al. 2011; Castro et al. 2015; 
Ng et al. 2015).
One of the problems in making comparisons between 
studies undertaken in young people with emerging mood 
disorders is that the sampling strategies and the param-
eters measured vary considerably between studies. For 
example, some studies focus on individuals at high risk 
of developing psychotic or mood disorders (identified by 
the presence of attenuated symptoms or temperamental 
style), whilst others recruit mixed samples of sympto-
matic and asymptomatic offspring of parents with UP or 
BD (e.g. Jones et al. 2006; Adan et al. 2010; Hidalgo et al. 
2009; Castro et al. 2015; Park et al. 2015). Most of these 
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studies use self-report assessments of sleep patterns or 
self-ratings of circadian rhythm such as the Morning–
Eveningness Questionnaire (MEQ) (Horne and Ostberg 
1976); the studies that do use objective measures such 
as actigraphy often focus on more traditional measures 
of sleep, such as sleep latency, waking after sleep onset 
and total sleep time (e.g. Castro et  al. 2015). Studies 
measuring circadian parameters and using actigraphy 
have often recruited young people with a wide range of 
disorders (anxiety, UP, BD, psychosis), but failed to take 
into account in the analyses the other variables known to 
influence circadian rhythms, such as age, pubertal status 
or BMI, etc., (Adan et al. 2010; Mansour et al. 2005; Caci 
et al. 2009; Kim et al. 2010; Tranel et al. 2015).
Despite the methodological heterogeneity (noted 
above), there is a growing research literature on acti-
graphic measures of circadian rhythms in youth. How-
ever, the clinical translation of some of these studies is 
reduced because many clinicians are unfamiliar with 
the relevance of some measures and/or are uncertain 
how to interpret some of the circadian parameters (e.g. 
alpha, beta, mesor) (Bellivier et al. 2015). As such, it can 
be helpful to select circadian markers that have shown 
differences between young people with mood disorders 
(compared to healthy control or other cases with mental 
disorders), and that can be easily understood by clini-
cians. The three obvious circadian parameters are ampli-
tude, acrophase and circadian rhythmicity index. Several 
studies report lower 24-hour activity rhythms (ampli-
tude) or changes in dim light melatonin onset for UP and 
BD (Teicher et  al. 1993; Armitage et  al. 2004; Robillard 
et al. 2013b; 2015), and for individuals at risk of BD (Bull-
ock and Murray 2014; Castro et al. 2015). The timing of 
maximal activity within a 24-h period (acrophase) has 
shown mixed results in UP and BD (Teicher et al. 1993; 
Robillard et  al. 2013a; 2015), but there is emerging evi-
dence of lower robustness of circadian rhythmicity in 
broad populations of young patients compared to healthy 
controls (e.g. Carpenter et al. 2015). The latter could be 
an interesting avenue for youth research as Gonzalez and 
colleagues (2014) recently demonstrated that a lower cir-
cadian rhythmicity index was a useful marker of illness 
severity in adults with BD and was correlated with total 
manic symptom score and with some individual manic 
symptoms. However, rhythmicity in comparable popula-
tions of UP and BD cases remains unexplored.
This study examines the role of selected markers of cir-
cadian rhythmicity in emerging mood disorders in young 
people aged 13–25  years who presented for the first 
time to clinical services. We focused on three key, easily 
interpretable parameters of circadian regulation, namely 
amplitude, acrophase and the circadian rhythmicity 
index. The aims were (a) to examine the associations 
between circadian parameters and age, gender, BMI, 
duration of illness and symptom severity in the total sam-
ple; (b) to compare these circadian parameters in BD and 
UP (after controlling for potential confounders).
Methods
Participants
With the approval of the Human Research Ethics Com-
mittee of The University of Sydney, individuals attending 
the local youth mental health services in and around Syd-
ney, Australia (Youth Mental Health Clinic at the Brain 
& Mind Research Institute, at The University of Sydney, 
and headspace in Campbelltown) were invited to partici-
pate in a series of studies of mental and physical health, 
including research on sleep and actigraphy.
Individuals included in this study were aged 
13–25  years, had a recent onset of a mood disorder 
meeting DSM-IV R criteria (APA. 2000), and were will-
ing and able to give written informed consent to par-
ticipate and to comply with study procedures. In those 
aged <16 years, additional written consent was obtained 
from their parents or legal guardians. The exclusion cri-
teria were (i) clinically assessed IQ  <70 or intellectual 
impairment, and/or history of head injury, (ii) mood dis-
order secondary to a medical condition or psychotic dis-
order, (iii) primary substance or alcohol misuse disorder, 
(iv) risk of suicide or self-harm, (v) regular use of medi-
cations that affect sleep, melatonin, circadian rhythms or 
alertness, (vi) evidence of other sleep (e.g. sleep apnoea, 
narcolepsy), neurological (e.g. epilepsy) or primary medi-
cal conditions that could explain the current depression 
and/or contribute to sleep–wake dysfunction, (vii) recent 
trans-meridian travel (i.e. potential for jet lag) or regular 
shift work.
Assessments
As described previously, participants completed a 
detailed clinical assessment conducted with a structured 
clinical proforma (Hickie et  al. 2014; Scott et  al. 2014, 
2015). For this study, the following data were used:
1. Demographics—current age and gender.
2. Clinical history—a research psychologist or psychia-
trist established that the individual had a UP or BD 
that met DSM-IV R diagnostic criteria. Although the 
cases were presenting to clinical services for the first 
time with syndromal illness episodes, this was not 
necessarily the first experience of clinical symptoms 
or sub-threshold syndromes. As such, we included a 
measure of time since onset of any symptoms, which 
is referred to as the duration of illness (and was 
estimated as current age minus age at first onset of 
any psychiatric symptoms) (Scott et  al. 2014). Basic 
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details of current medications (class of medica-
tions prescribed) and body mass index (BMI) were 
recorded.
3. Symptom severity—observer ratings of mood symp-
toms were undertaken using the 17-item version of 
the Hamilton Rating Scale for Depression (HRSD; 
Hamilton, 1960) and the 11-item version of the 
Young Mania Rating Scale (YMRS) (Young et  al. 
1978) in all participants.
4. Sleep profile—self-report and observer-rated assess-
ments of sleep were undertaken for other studies by 
the research group, but are not reported here (for 
details see Robillard et al. 2014).
In this study, objective recordings of sleep profile were 
undertaken for between 5 and 14 days (median 10 days) 
using an actiwatch (Actiwatch-64/L/2/Spectrum, Philips 
Respironics, USA) and sleep–wake detection was con-
ducted automatically with Actiware 5.0 software (Philips 
Respironics) using the medium sensitivity threshold.
To characterise the circadian profile of the activity-rest 
cycle, individual actigraphy datasets were fitted to an 
extended Cosinor model using GraphPad Software. In 
this study, we estimated three key parameters, namely:
(i)  Amplitude: a measure of the range of activity levels 
across the 24-h period,
(ii) Acrophase: a phase marker that can be used as a 
measure of an advance or delay in time of maxi-
mum activity, and
(iii) Circadian Rhythmicity Index (R2): an indicator of the 
strength or robustness of circadian rhythms, and also 
referred to as R2 or the coefficient of determination. 
The circadian rhythmicity index is a ‘goodness of fit’ 
measure and higher values indicate smaller discrep-
ancies between actigraphy data and values predicted 
by the Cosinor model and higher scores represent 
more robust rhythms (for an explanation of how to 
undertake the analysis see Marler et al. 2006).
Statistical analyses
All analyses used an alpha of 0.05 and were conducted 
using SPSS (version 21).
Clinical and demographic characteristics for the UP 
and BD groups were compared using univariate analy-
ses (t-tests, Mann–Whitney U and Fisher’s exact test). 
Pearson’s product moment correlational analyses were 
used to examine any associations between each circadian 
parameter (amplitude, acrophase and R2) and continuous 
variables measuring demographic and illness character-
istics i.e. current age, duration of illness, BMI, HRSD and 
YMRS in the total sample. Next, we conducted an analy-
sis of variance (ANOVA) for each circadian parameter 
according to mood disorder subtype (UP or BD) with 
gender, current age, duration of illness, BMI, HRSD and 
YMRS as covariates.
Results
As shown in Table 1, the groups were well matched for 
current age and gender and there were no statistically sig-
nificant differences in duration of illness, BMI or symp-
tom severity scores. The YMRS scores were not normally 
distributed, but the higher median score in the BD group 
was not significantly greater than in the UP group. Most 
cases of both UP and BP were being prescribed only one 
medication, and the majority of the sample received an 
antidepressant. Some BD cases were co-prescribed a 
mood stabilizer or atypical antipsychotic, but prescribing 
patterns did not differ significantly between the diagnos-
tic groups.
For the total sample, the mean amplitude was 2.04 (SD 
0.76), the mean acrophase was 16.19 h (SD 1.65) and the 
mean R2 was 0.42 (SD 0.13); there were no significant dif-
ferences according to gender. As shown in Table 2, cur-
rent age was significantly negatively correlated with R2 
(r −0.40; p =  0.001), whilst duration of illness was sig-
nificantly negatively correlated with amplitude (r −0.25; 
p  =  0.045) and with R2 (r −0.33; p  =  0.01). The BMI 
was not associated with any circadian parameters. With 
regard to current symptom severity, the HRSD was not 
Table 1 Sample characteristics
IQR Interquartile range
a t-test: t = 1.94, p = 0.06
b Mann–Whitney U test: p = 0.07
c Fisher’s exact test: p = 0.09






Mean (SD) Mean (SD)
Current agea 18.66 (3.01) 19.95 (2.13)
Duration of illness 4.45 (3.59) 5.92 (2.87)
Body Mass Index 23.67 (2.89) 24.05 (4.77)
Hamilton Rating Scale for 
Depression
13.97 (7.90) 12.44 (7.08)
Young Mania Rating Scaleb 
Median (IQR)
2 (0, 3) 3.5 (1, 5)
Number (%) Number (%)
Females 20 (61) 19 (63)
Medicationsd
 Antidepressant 25 (76) 19 (77)
 Atypical antipsychotic 5 (15) 7 (23)
 Mood stabilizerc 2 (6) 5 (17)
 Other 2 (6) 0 (0)
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significantly associated with circadian parameters, but 
the YMRS score was significantly positively correlated 
with acrophase (r 0.28; p = 0.03).
The ANOVA demonstrated that, after taking into 
account potential confounders (age, gender, duration 
of illness, BMI, HRSD, YMRS), differences between the 
diagnostic groups were significant for R2 (mean UP v. 
BD = 0.43 v 0.40; F = 2.34; df = 6, 56; p = 0.044), but not 
for amplitude (mean = 2.14 v. 1.84; F = 1.51; p = 0.09) or 
acrophase (mean = 16.07 v 16.30 h; F = 1.17; p = 0.33). 
As shown in Figs.  1 and 2, symptom severity and diag-
nostic group were the main to the significant model for 
R2. The regression slopes for the correlations between R2 
and HRSD or R2 and YMRS are different in BD compared 
to UP cases. There is little variation in R2 across differ-
ent levels of symptom severity in UP, but higher levels of 
either manic or depressive symptoms are associated with 
a significantly lower circadian rhythmicity index in BD 
cases.
Discussion
The study set out to explore two aspects of circadian 
rhythms in youth with mood disorders. First, the asso-
ciations between the selected circadian parameters and 
basic demographic and clinical characteristics (inde-
pendent of mood disorder subtype), and second, whether 
any specific parameters were more likely to be disturbed 
in UP compared to BD.
Table 2 Correlations between clinical characteristics and circadian parameters
*p < 0.05; **p < 0.01 (see text for exact levels of significance)
Current age Duration of illness Body mass index HRSD YMRS
Amplitude 0.06 −0.25* 0.10 −0.03 −0.10
Acrophase 0.21 0.12 0.03 0.07 0.28*
Circadian rhythmicity index (R2) −0.40** −0.33** −0.12 −0.20 −0.17
Fig. 1 Correlation between Hamilton rating scale for depression score and circadian rhythmicity (R2) in unipolar and bipolar disorders
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The correlational analyses undertaken in this study 
show a relationship between the selected circadian 
rhythm parameters, the first treated episode of mood 
disorders in youth and current age. First, longer dura-
tion of illness (defined as the time since the first onset 
of any symptoms) was associated with a reduced circa-
dian rhythmicity index and lower levels of activity over 
24  h. Second, there was a significant inverse correla-
tion between increasing age and robustness of circadian 
rhythmicity. Third, acrophase was associated with cur-
rent mental state, being significantly correlated with the 
level of manic but not depressive symptoms.
Taken together, these findings could suggest that weak-
ened rhythmicity and lower 24-h activity are markers of 
vulnerability to developing syndromal episodes of UP 
or BD. We cannot state categorically that they are trait 
markers for UP or BD as, even in this first-treated sam-
ple, many individuals had a history of subsyndromal 
symptoms. So, the circadian disturbances could be a 
consequence of longer duration of symptoms. However, 
we can hypothesis that these circadian parameters are 
indicators that mood symptoms will meet the diagnostic 
threshold for a full syndromal episode (Bullock and Mur-
ray 2014; Castro et  al. 2015). In contrast, the acrophase 
findings suggest that the timing of maximum activity 
may be a state marker of manic symptom severity. This 
finding is in line with some but not all previous studies. 
Several studies in young people failed to show an asso-
ciation between acrophase and depression (Teicher et al. 
1993; Robillard et al. 2015), whilst several studies in older 
adults have noted an association between mania and 
acrophase (although findings are inconsistent with regard 
to phase advance or delay) (Salvatore et al. 2008; Ng et al. 
2015).
We suggest that the findings regarding current age are 
important as they emphasise that there is a developmental 
trajectory for the variability in 24-h rhythms that should 
be taken into account when planning studies of sleep and 
mood disorders (Mansour et al. 2005; Caci et al. 2009; Kim 
et  al. 2010). This is especially important in studies that 
focus on populations of adolescents and young adults, as 
age-matching may be needed to avoid misinterpreting any 
circadian disruption as an association with illness charac-
teristics as compared to demography (Fares et  al. 2015). 
Similarly, previous studies have demonstrated an associa-
tion between gender and/or increased BMI and circadian 
disturbance in adolescents and young adults (e.g. Arora 
and Taheri 2014; Tranel et al. 2015), and we suggest that 
Fig. 2 Correlation between Young mania rating scale score and circadian rhythmicity (R2) in unipolar and bipolar disorders
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these factors also need to be routinely reported in future 
studies. The lack of significant associations between gen-
der and circadian disturbance may be due to recruiting 
a post-pubertal sample (or the sample size); but the lack 
of association between BMI and circadian disturbance 
was somewhat unexpected. It may be because the sam-
ple did not manifest high levels of obesity (the mean BMI 
was <25) or it may be a consequence of the relatively small 
sample size (Boudebesse et al. 2015).
The examination of mood disorder subtypes suggests 
that the circadian rhythmicity index demonstrates a 
stronger association with illness episodes in BD as com-
pared to UP. After taking into account possible confound-
ers, we found that rhythmicity in BD was lower than in 
UP. Furthermore, whilst there were little apparent differ-
ences in rhythmicity across all levels of symptom sever-
ity in UP, reduced rhythmicity was associated with both 
higher HRSD and higher YMRS scores in BD. A differ-
ence between UP and BD might be anticipated for R2 and 
YMRS scores, as we would not anticipate high levels of 
manic-like symptoms in the UP group and also, previous 
publications suggest that there is heightened variability in 
circadian markers across mood phases in BD (Novakova 
et al. 2015). However, the finding that the BD group, but 
not the UP group, also showed lower rhythmicity in asso-
ciation with higher levels of depressive symptoms is an 
important finding that warrants replication. The findings 
may indicate that weakened circadian rhythms, especially 
associated with increasing severity of depressive symp-
toms, is a more specific marker of BD than of UP in youth.
The current study has a number of limitations. First, 
the sample size limits the number of statistical analyses 
that could be planned and performed. Also, it meant 
we could not justify undertaking any further sub-group 
analyses to determine if any specific constellations of 
manic or depressive symptoms were associated with 
weakened rhythmicity (as reported by Gonzalez et  al. 
2014). Second, although the age range was limited to the 
post-pubertal and early adult period, there were trends 
towards significant differences between the UP and BD 
groups in mean age (p = 0.06) and the BD group had a 
longer mean duration of symptoms. Without specific age 
and gender matching, we cannot rule out the possibility 
that these differences contributed to some extent to the 
findings in this study. Third, although the cases were pre-
senting to the clinical services for the first time, the study 
participants were nearly all receiving medication by the 
time they undertook the actigraphy recording of their 
sleep–wake patterns. Although there were no significant 
differences in medications received by the UP and BD 
cases, it is possible that some findings might be associ-
ated with, or the findings were enhanced by any effects 
associated with the medications prescribed. Lastly, 
although symptom levels were in the mild to moderate 
range, it does make it difficult to distinguish state and 
trait abnormalities in circadian rhythms.
Conclusions
In conclusion, the study selected circadian markers (acro-
phase, amplitude and circadian rhythmicity) that are easy 
to interpret clinically and that capture a holistic picture 
of circadian rhythm disruption in mood disorders. The 
findings provide evidence for circadian disturbances in 
youth with mood disorders that warrant further investi-
gation, especially the possibility that the circadian rhyth-
micity index is lower in BD compared to UP and is less 
robust in the face of increasing levels of manic or depres-
sive symptoms.
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